Author

Isabella Ranieri

Beth Israel Deaconess Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex TokeriD· 1 shared Alexandra IndegliaiD· 1 shared Alissandra L. HillisiD· 1 shared Franziska Michor AiD· 1 shared Jenny M. HogstromiD· 1 shared Jingchao WangiD· 1 shared John G. ClohessyiD· 1 shared Jonah LeeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex TokerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity

Josefina Mendez, Simone Bruno, Alexandra Indeglia, Tashbib Khan, Isabella Ranieri, Jingchao Wang, Jenny M. Hogstrom, Alissandra L. Hillis, Jonah Lee, John G. Clohessy, Taru E. Muranen, Wenyi Wei, Franziska Michor A, Karen M. Cichowski, Alex Toker

This study identifies BRD2 as a co-targetable vulnerability with PI3K/AKT inhibitors in breast cancer, showing that BRD2 phosphorylation is required for chromatin binding and that targeting BRD2 enhances drug efficacy.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology